W. Brett Ingersoll serves as Executive at Talecris Biotherapeutics Holdings Corp., where they oversee executive responsibilities. Since joining the company, W. Brett Ingersoll has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 1, 2011 involved selling 3,019 shares valued at $0.
W. Brett Ingersoll currently holds 3,019 shares of Talecris Biotherapeutics Holdings Corp. (TLCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, W. Brett Ingersoll has been a net neutral trader of TLCR stock. They have purchased $0 and sold $0 worth of shares.
W. Brett Ingersoll's most recent insider trade was on Jun 1, 2011, when they sold 3,019 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |